Federal contractor profile
Regeneron Pharmaceuticals: Federal Contracts, Agencies & Awards
Data through 2026-09-28 · FY2026 to date
- Obligations, FY2026 to date
- $279M
- Contract awards
- 3
- Average award size
- $93.1M
| Item | Obligations |
|---|---|
| FY21 | $5.6B |
| FY22 | $494K |
| FY23 | $326M |
| FY24 | $0 |
| FY25 | -$332M |
| FY26 | $279M |
Regeneron Pharmaceuticals won $279M in FY2026 to date.
In FY2026 to date, Regeneron Pharmaceuticals won $279M across 3 contract awards. The average award size was $93.1M.
Which agencies buy from Regeneron Pharmaceuticals?
Department of Health and Human Services accounted for $279M of Regeneron Pharmaceuticals's federal contract obligations in FY2026 to date, or 100.0% of the company's federal work.
What does Regeneron Pharmaceuticals sell to the government?
Research and Development in Biotechnology is Regeneron Pharmaceuticals's largest federal market by obligations, at $279M in FY2026 to date, a 100.0% share of its federal business.
| Rank | Award | Award Amount | Awarding Agency | Ends |
|---|---|---|---|---|
| 1 | HHSO100201700016C | $974M | Department of Health and Human Services | 2031-09-29 |
| 2 | HHSO100201700020C | $279M | Department of Health and Human Services | 2027-09-25 |
| 3 | HHSO100201600023C | $8.6M | Department of Health and Human Services | 2022-09-30 |
| Award | Awarding Agency | Award Value | Ends |
|---|---|---|---|
| HHSO100201700020C | Department of Health and Human Services | $279M | 2027-09-25 |
| Detail | Registration |
|---|---|
| Unique Entity ID (UEI) | N3F9MH7E6HD6 |
| Headquarters | Tarrytown, NY |
| Business types | Category business; Corporate entity not tax exempt; Manufacturer of goods; Other than small business; Special designations; Us owned business |
This is the free layer.
GovHub customers get the live version, filters, exports, and AI proposal drafting on top of this data.
No credit card required · 14-day free trial
Frequently asked questions
How much does Regeneron Pharmaceuticals make from federal contracts?
Regeneron Pharmaceuticals won $279M in federal contract obligations in FY2026 to date, across 3 awards.
Which agencies buy from Regeneron Pharmaceuticals?
Department of Health and Human Services is Regeneron Pharmaceuticals's largest federal customer, with $279M obligated in FY2026 to date.
What does Regeneron Pharmaceuticals sell to the government?
Regeneron Pharmaceuticals's largest federal market is Research and Development in Biotechnology, with $279M in obligations in FY2026 to date.
Which Regeneron Pharmaceuticals contracts are expiring soon?
Regeneron Pharmaceuticals's largest contract expiring in the next 12 months is a $279M award from Department of Health and Human Services, with a period of performance ending in September 2027.
Found your market? GovHub writes the proposal.
Turn this market intelligence into a submitted, compliant federal proposal, faster.
No credit card required · 14-day free trial